FLCN、BAP1、SDH和MET胚系突变相关肾癌的患病率与影像学特征
在25220例肿瘤患者中,FLCN、BAP1、SDH和MET胚系突变总患病率为0.31%,其中23%被诊断为肾细胞癌。遗传性肾细胞癌多表现为边缘不清、中央无强化区、不均匀强化,与其他非遗传性肾细胞癌的影像表现重叠;其他良性实性肾脏病变的患病率高达11%。
要点
- 在肿瘤队列中,FLCN、BAP1、SDH和MET胚系突变总患病率为0.31%。
- 79例突变携带者中23%诊断为肾细胞癌,影像表现可与散发性肾癌重叠。
- 遗传性肾癌常见边缘不清、中央无强化区(囊性或坏死)及不均匀强化。
核心结论
- 在这个肿瘤队列中,FLCN、BAP1、SDH和MET突变存在比例小于1%;在研究样本量限制内,遗传性肾细胞癌的影像表现与非遗传性肾细胞癌重叠,其他相关良性实性肾脏病变(复杂囊肿除外)的患病率高达11%。
研究设计与样本
- 回顾性识别2015年至2021年间25220例接受超过70个癌症易感基因面板前瞻性胚系分析的患者中携带FLCN、BAP1、SDH或MET突变者;若存在肾细胞癌,由两名放射科医师独立评估基线CT和MRI检查。
关键影像表现/征象
- 大多数遗传性肾细胞癌表现为边缘不清、中央无强化区(囊性或坏死)、不均匀强化,并伴有多种其他CT和MR影像学特征,与非遗传性肾细胞癌的影像表现重叠。
局限性
- 研究样本量有限(原文述「within the study sample size limits」),遗传性肾细胞癌影像表现与非遗传性肾细胞癌重叠的结论受此限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To investigate the prevalence of FLCN, BAP1, SDH, and MET mutations in an oncologic cohort and determine the prevalence, clinical features, and imaging features of renal cell carcinoma (RCC) associated with these mutations. Secondarily, to determine the prevalence of encountered benign renal lesions. Materials and Methods From 25 220 patients with cancer who prospectively underwent germline analysis with a panel of more than 70 cancer-predisposing genes from 2015 to 2021, patients with FLCN, BAP1, SDH, or MET mutations were retrospectively identified. Clinical records were reviewed for patient age, sex, race/ethnicity, and renal cancer diagnosis. If RCC was present, baseline CT and MRI examinations were independently assessed by two radiologists. Summary statistics were used to summarize continuous and categorical variables by mutation. Results A total of 79 of 25 220 (0.31%) patients had a germline mutation: FLCN, 17 of 25 220 (0.07%); BAP1, 22 of 25 220 (0.09%); SDH, 39 of 25 220 (0.15%); and MET, one of 25 220 (0.004%). Of these 79 patients, 18 (23%) were diagnosed with RCC (FLCN, four of 17 [24%]; BAP1, four of 22 [18%]; SDH, nine of 39 [23%]; MET, one of one [100%]). Most hereditary RCCs demonstrated ill-defined margins, central nonenhancing area (cystic or necrotic), heterogeneous enhancement, and various other CT and MR radiologic features, overlapping with the radiologic appearance of nonhereditary RCCs. The prevalence of other benign solid renal lesions (other than complex cysts) in patients was up to 11%. Conclusion FLCN, BAP1, SDH, and MET mutations were present in less than 1% of this oncologic cohort. Within the study sample size limits, imaging findings for hereditary RCC overlapped with those of nonhereditary RCC, and the prevalence of other associated benign solid renal lesions (other than complex cysts) was up to 11%. Keywords: Familial Renal Cell Carcinoma, Birt-Hogg-Dubé Syndrome, Carcinoma, Renal Cell, Paragangliomas, Urinary, Kidney © RSNA, 2024.
引用
- Charbel C, Causa Andrieu PI, Soliman M, et al. The Prevalence and Radiologic Features of Renal Cancers Associated with FLCN, BAP1, SDH, and MET Germline Mutations. Radiol Imaging Cancer. 2024. PMID: 38456787. doi:10.1148/rycan.230063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。